-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Akoya Biosciences, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q1 2025.
- Akoya Biosciences, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was $11K, a 70.3% decline year-over-year.
- Akoya Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was $4K.
- Akoya Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$51K, a 246% decline from 2022.
- Akoya Biosciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $35K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)